Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1279
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 412-422
Open Access | Times Cited: 639
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 518
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
Alyson M. Cavanaugh, Kevin B. Spicer, Douglas Thoroughman, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 32, pp. 1081-1083
Open Access | Times Cited: 243
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Lauren Forchette, William Sebastian, Tuoen Liu
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1037-1051
Open Access | Times Cited: 224
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
Chantal B. F. Vogels, Mallery I. Breban, Isabel M. Ott, et al.
PLoS Biology (2021) Vol. 19, Iss. 5, pp. e3001236-e3001236
Open Access | Times Cited: 221
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Yaping Wang, Ruchong Chen, Fengyu Hu, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101129-101129
Open Access | Times Cited: 216
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 191
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 167
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
Isabella A. T. M. Ferreira, Steven A. Kemp, Rawlings Datir, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 6, pp. 989-994
Open Access | Times Cited: 163
Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United States
Yuehan Ai, Angela Davis, Dan Jones, et al.
The Science of The Total Environment (2021) Vol. 801, pp. 149757-149757
Open Access | Times Cited: 155
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 138
Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil
Severino Jefferson Ribeiro da Silva, Lindomar Pena
One Health (2021) Vol. 13, pp. 100287-100287
Open Access | Times Cited: 126
SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity
Akatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 105
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, et al.
medRxiv (2021)
Open Access | Times Cited: 103
The Emerging Concern and Interest SARS-CoV-2 Variants
Edyta Janik, Marcin Niemcewicz, Marcin Podogrocki, et al.
Pathogens (2021) Vol. 10, Iss. 6, pp. 633-633
Open Access | Times Cited: 103
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 4, pp. 734-742
Open Access | Times Cited: 102
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant
Jiahui Chen, Guo‐Wei Wei
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 17, pp. 3840-3849
Open Access | Times Cited: 83
The puzzling mutational landscape of the SARS‐2‐variant Omicron
Jacques Fantini, Nouara Yahi, Philippe Colson, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2019-2025
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top